Schizophrenia Research
Volume 118, Issue 1 , Pages 34-40, May 2010

Executive function in schizophrenia: Influence of substance use disorder history

  • Roberto Rodriguez-Jimenez

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
    • Corresponding Author InformationCorresponding author. Psychiatry Department, Hospital Universitario 12 de Octubre, Av. Cordoba s/n, 28041, Madrid, Spain. Tel.: +34 91 390 80 22; fax: +34 91 390 85 38.
  • ,
  • Alexandra Bagney

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • Isabel Martinez-Gras

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • Guillermo Ponce

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • Eva Maria Sanchez-Morla

      Affiliations

    • Department of Psychiatry, Hospital General Universitario, Guadalajara, Spain
  • ,
  • Maria Aragües

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • Gabriel Rubio

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • Miguel Angel Jimenez-Arriero

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • Jose Luis Santos

      Affiliations

    • Department of Psychiatry, Hospital Virgen de La Luz, Cuenca, Spain
  • ,
  • Tomas Palomo

      Affiliations

    • Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
  • ,
  • PARG

      Affiliations

    • Psychosis and Addictions Research Group (PARG): L. Agüera, S. Alfonso, M. Aragües, A. Bagney, J. Ballester, J.J. Belloso, E. Bermudez, M. Caballero, J. Camarasa, P. Cano, J. Diez, J. Hoenicka, P. Holgado, M.A. Jimenez-Arriero, R. Jurado, I. Martinez-Gras, M.J. Muñiz, M. Navio, T. Palomo, G. Ponce, J. Ramos, R. Rodriguez-Jimenez, J. Rodriguez-Torresano, G. Rubio, I. Rubio, E.M. Sanchez-Morla, J.L. Santos, S. Solera, S. Vega, C. Villanueva, M.J. del Yerro.

Received 6 May 2009; received in revised form 27 July 2009; accepted 24 September 2009. published online 26 October 2009.

Abstract 

Cognitive function in schizophrenia has been associated with different sociodemographic and clinical variables. Substance use disorder (SUD) history has also been associated with cognition in schizophrenia; however, contradictory results have been found regarding its influence on cognitive function. Our aim was to study the relationship between executive function and a) age, b) duration of illness, c) number of psychotic episodes, d) positive symptoms, and e) negative symptoms, in a sample of schizophrenic patients, and secondly to study whether these relationships persisted after stratification of the sample according to the presence or absence of SUD history. A final sample of 203 schizophrenic patients were evaluated for psychotic symptoms using the PANSS, and assessed using a neuropsychological battery to calculate a composite executive function score. Linear regression analyses were performed, with this executive score as the dependent variable, and age, duration of illness, number of psychotic episodes, positive PANSS score and negative PANSS score as independent variables. For the total sample, the regression model showed three variables to be significant predictors of the executive score: age (p=0.004), number of episodes (p=0.027), and PANSS negative score (p=0.003). However, once the sample was stratified, the regression model showed age (p=0.011) and number of episodes (p=0.011) to be predictor variables for the executive score in the group of schizophrenic patients with SUD history, while age (p=0.028) and PANSS negative score (p=0.006) were predictors in the group of schizophrenic patients without such history. These findings highlight the importance of considering SUD history in studies of cognitive function in schizophrenia.

Keywords: Schizophrenia, Cognitive function, Executive function, Substance use disorder, Dual diagnosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(09)00469-1

doi:10.1016/j.schres.2009.09.025

Schizophrenia Research
Volume 118, Issue 1 , Pages 34-40, May 2010